Penn Medicine Provider
Dermatology
Katherine Thacker Steele, MD
5.0
(378)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman

About me

  • Associate Professor of Clinical Dermatology

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Massachusetts General Hospital/Brigham and Women’s Hospital
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

378 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
professional
March 2025
5.0
5.0
she listened to my concerns.
March 2025
5.0
5.0
professional, punctual and polite
March 2025
5.0
5.0
i would not hesitate to recommend dr steele to family and friends.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Steele is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Yoon I, Do N, Vazquez T, Elder D, Steele K, Rosenbach M Injection site reaction to teclistamab in a patient with multiple myeloma , JAAD Case Reports, 56: 2024,48-50


Milbar H, Caplan A, Schwab R, Coromilas A, Baumrin E, Forrestel A, Steele K, Micheletti R, Perl A, Rosenbach M Vitamin C deficiency in patients with acute myeloid leukemia: a case series and review of the literature , Blood Adv, 7(19): 2023,5780-83


Wei J, Wachuku C, Berk-Krauss J, Steele KT, Rosenbach M, Messenger E Severe cutaneous ulcerations secondary to xylazine (tranq): A case series , JAAD Case Rep, 36: 2023,89-91


Bhattacharya S, Basu S, Sheng E, Murphy C, Wei J, Kersh A, Nelson C, Bryer J, Ashchyan H, Steele K, Forrestel A, Seykora J, Micheletti R, James W, Rosenbach M, Leung T Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome. , J Clin Invest, 133(1): 2023,e162137


Godse R, Rauck C, Woods R, Steele K, Elenitsas R Two Cases of Insulin-Derived Amyloidosis With Acanthosis Nigricans-Like Changes , Am J Dermatopathol, 44(12): 2022,979-80


Alam M, Lewis W, Harp J, Steele K, Rosenbach M, Micheletti R Cutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the Pandemic , Cutis, 107(4): 2021,209-15


Steele K, Markova A Cutaneous adverse events of molecularly targeted therapy and other biologic agents used for cancer therapy , Drews RE, ed. UpToDate. Waltham, MA: UpToDate, Inc.: 2021


Stephens M, Aderibigbe O, Steele K, Elder D, Glaser L, Jacob J, Rosenbach M Draining dorsal hand pustules, nodules, and ulcers in a patient with immunosuppression , JAAD Case Reports: 2019


Buter J, Steele K, Chung K, Elzinga K. Extravasation injury from chemotherapy and other non-antineoplastic vesicants , Drews RE, ed. UpToDate. Waltham, MA: UpToDate, Inc. Published online: 2019


Steele K, Miller C “Melanoma in situ.” In: Alam, Murad (Ed.) Evidence-Based Procedural Dermatology, 2nd Edition , 2nd Edition. Springer: 2019